GlassScriptPhysician profile
Morey S Klein
NPI 1245218619
$4,563.55
in general payments reported to CMS, 2019-2025
22 companies · $923 in 2025
The $923 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $390 · 2021: $516 · 2022: $507 · 2023: $1,014 · 2024: $774 · 2025: $923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,710.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,010.12 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $793.12 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $639.68 | 2021-2025 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $627.57 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $214.02 | 2021-2025 | Verquvo |
| Kestra Medical Technology Services, INC. | $172.59 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $172.47 | 2021-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.36 | 2021-2024 | Jardiance |
| Artivion, INC. | $117.94 | 2025 | Cryovalve Sg Pulmonary Human Heart Valve, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Janssen Pharmaceuticals, INC | $109.75 | 2019-2022 | |
| Pfizer INC. | $105.76 | 2021-2025 | |
| Daiichi Sankyo INC. | $84.27 | 2023-2024 | Injectafer |
| Esperion Therapeutics, INC. | $83.56 | 2021-2022 | |
| Amgen INC. | $59.95 | 2021-2025 | Repatha |
| Atricure, INC. | $58.07 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $39.30 | 2023-2025 | Ffrct |
| Amarin Pharma, INC. | $38.11 | 2020-2022 | |
| Novo Nordisk INC | $24.64 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.16 | 2025 | Wainua |
| Medtronic, INC. | $20.83 | 2025 | Symplicity G3 |
| Astellas Pharma US INC | $16.71 | 2022 | |
| Medtronic Vascular, INC. | $16.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morey Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.